From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Join us for this must attend, Australasian COVID-19 Conference taking place 21 – 22 July 2022

Share the link to this page with others to keep them informed

Are you a GP, nurse, researcher, policy maker, infectious disease physician, virologist, scientist or consumer with an interest in COVID? We encourage you attend this conference.

Keynotes Announced: Associate Professor Penny Moore, South African Chair of Virus-Host Dynamics, Wits University and the National Institute for Communicable Diseases will be presenting on: SARS CoV variants – how they are identified, and what is on the horizon?

And Dr Muge Cevik, School of Medicine, Clinical Fellow, Infection and Global Health Division, St Andrews, UK will be presenting on: The UK response to COVID – what can we learn from it?

Topics you can expect to hear about in the conference:

  • Long COVID
  • Vaccines, manufacturing & clinical trials
  • Therapy implementation
  • Pandemic Preparedness & Modelling
  • Communication, misinformation & health literacy
  • What does the future hold with new variants?
  • Priority populations and communities

View the conference website for more details.

Don’t delay, register today: Register Now

Early bird deadline: 12 June 2022